Solvency II to curb renascent with-profit sector



The with-profit – or participating – insurance product sector is likely to be curbed by the increasing capital costs that will be imposed by Solvency II, according to research by US bank Morgan Stanley and London-based consultancy Oliver Wyman. 

According to the report, Solvency 2: Quantitative & Strategic Impact, the realities of the new regulatory regime will force firms to either retreat entirely from the sector or redesign their products. According to Astrid Jaekel, a consultant at Oliver

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: